Ascend Wellness Holdings, Inc. (OTCMKTS:AAWH – Get Free Report) was the recipient of a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 45,126 shares, a growth of 201.4% from the July 15th total of 14,974 shares. Based on an average daily volume of 88,633 shares, the short-interest ratio is presently 0.5 days. Approximately 0.0% of the company’s shares are short sold.
Wall Street Analyst Weigh In
Separately, Zacks Research upgraded shares of Ascend Wellness from a “strong sell” rating to a “hold” rating in a report on Tuesday, May 12th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold”.
Check Out Our Latest Analysis on AAWH
Ascend Wellness Price Performance
Ascend Wellness (OTCMKTS:AAWH – Get Free Report) last issued its earnings results on Wednesday, August 12th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.07. Ascend Wellness had a negative return on equity of 1,099.51% and a negative net margin of 26.24%. Research analysts anticipate that Ascend Wellness will post -0.32 EPS for the current year.
About Ascend Wellness
Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores.
Featured Stories
- Five stocks we like better than Ascend Wellness
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Ascend Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascend Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
